
A method to distinguish between the de novo induction of thymidine kinase mutants and the selection of pre-existing thymidine kinase mutants in the mouse lymphoma assay
Keywords: Mouse lymphoma assay; Thymidine analogue; Mutant selection; Mutant frequency